Referanslar

1. Siegel RL, Miller KD, Wagle N S, Jemal A. Cancer statistics, 2023. CA: a cancer journal for clinicians. 2023;73(1), 17-48. [Crossref]  [PubMed]
2. Heath A K, Muller D C, van den Brandt P A, Critselis E, Gunter M, et al. Diet-wide association study of 92 foods and nutrients and lung cancer risk in the European Pros- pective Investigation into Cancer and Nutrition study and the Netherlands Cohort Study. International journal of can- cer. 2022; 151(11), 1935-46. [Crossref]  [PubMed]
3. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. II. Mechanisms. Cancer causes & control: CCC. 1991; 2(6), 427-442. [Crossref]  [PubMed]
4. Virtamo J, Taylor PR, Kontto J, Männistö S, Utriainen M, Weinstein SJ, et al. Effects of -tocopherol and -carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the Alpha-tocopherol, Be- ta-carotene Cancer Prevention Study. International journal of cancer. 2014; 135(1), 178-185. [Crossref]  [PubMed]
5. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cul- len MR, Glass A, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Ret- inol Efficacy Trial. Journal of the National Cancer Institute. 1991; 88(21), 1550-1559. [Crossref]  [PubMed]
6. Zhang Y, Yang J, Na X, Zhao A. Association between -car- otene supplementation and risk of cancer: a meta-analysis of randomized controlled trials. Nutrition reviews. 2023; 81(9), 1118-1130. [Crossref]  [PubMed]
7. Kordiak J, Bielec F, Jabłoński S, Pastuszak-Lewandoska D. Role of Beta-Carotene in Lung Cancer Primary Chemopre- vention: A Systematic Review with Meta-Analysis and Me- ta-Regression. Nutrients. 2022; 14(7), 1361. [Crossref]  [PubMed]
8. Franco CN, Seabrook LJ, Nguyen ST, Leonard JT, Albrecht LV. Simplifying the B Complex: How Vitamins B6 and B9 Modulate One Carbon Metabolism in Cancer and Be- yond. Metabolites. 2022; 12(10), 961. [Crossref]  [PubMed]
9. Ebbing M, Bønaa KH, Nygård O, Arnesen E, Ueland PM, Nordrehaug JE et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 2009; 302:2119-26. PubMed: 19920236 [Crossref]  [PubMed]
10. Brasky TM, White E, Chen C-L. Long-Term, Supplemental, One-Carbon Metabolism-Related Vitamin B Use in Relati- on to Lung Cancer Risk in the Vitamins and Lifestyle (VI- TAL) Cohort. J Clin Oncol Off J Am Soc Clin Oncol. 2017; 35:3440-8. [Crossref]  [PubMed]
11. Luu HN, Wang R, Jin A, Koh WP, Yuan JM. The association between dietary vitamin B12 and lung cancer risk: findings from a prospective cohort study. European journal of cancer prevention: the official journal of the European Cancer Pre- vention Organisation (ECP). 2021; 30(3), 275-281. [Crossref]  [PubMed]
12. Takata Y, Shu XO, Buchowski M S, Munro HM, Wen W, Steinwandel MD, et al. Food intake of folate, folic acid and other B vitamins with lung cancer risk in a low-income pop- ulation in the Southeastern United States. European journal of nutrition.2020; 59(2), 671-683. [Crossref]  [PubMed]
13. Bassett JK, Hodge AM, English DR, Baglietto L, Hopper JL, Giles GG et al. Dietary intake of B vitamins and methionine and risk of lung cancer. European journal of clinical nutri- tion. 2012; 66(2), 182-187. [Crossref]  [PubMed]
14. Hartman TJ, Woodson K, Stolzenberg-Solomon R, Virtamo J, Selhub J, Barrett M J, et al. Association of the B-vitamins pyridoxal 5'-phosphate (B (6)), B (12), and folate with lung cancer risk in older men. American journal of epidemiolo- gy. 2001;153(7), 688-694. [Crossref]  [PubMed]
15. Durda K, Kąklewski K, Gupta S, Szydłowski M, Baszuk P, Jaworska-Bieniek K, et al. Serum folate concentration and the incidence of lung cancer. PloS one. 2017; 12(5), e0177441. [Crossref]  [PubMed]
16. Stanisławska-Sachadyn A, Borzyszkowska J, Krzemiński M, Janowicz A, Dziadziuszko R, Jassem J, et al. Folate/ho- mocysteine metabolism and lung cancer risk among smok- ers. PloS one. 2019; 14(4), e0214462. [Crossref]  [PubMed]
17. Bae JM. Serum Folate Levels and Lung Cancer Risk: A Meta- Epidemiological Study of Population-based Case-Control Studies. Asian Pacific journal of cancer prevention APJCP. 2020; 21(6), 1829-1833. [Crossref]  [PubMed]
18. Brasky TM, Ray RM, Navarro SL, Schenk JM, Newton AM, Neuhouser ML. Supplemental one-carbon metabolism relat- ed B vitamins and lung cancer risk in the Women's Health Initiative. International journal of cancer. 2020; 147(5), 1374-1384. [Crossref]  [PubMed]
19. Takata Y, Cai Q, Beeghly-Fadiel A, Li H, Shrubsole MJ, Ji BT, et al. Dietary B vitamin and methionine intakes and lung cancer risk among female never smokers in China. Cancer causes & control: CCC. 2012; 23(12), 1965-75. [Crossref]  [PubMed]
20. Luo J, Shen L, Zheng D. Association between vitamin C intake and lung cancer: a dose-response meta-analysis. Sci- entific reports. 2014; 4, 6161. [Crossref]  [PubMed]
21. Shareck M, Rousseau MC, Koushik A, Siemiatycki J, Parent ME. Inverse Association between Dietary Intake of Selected Carotenoids and Vitamin C and Risk of Lung Cancer. Fron- tiers in oncology. 2017; 7, 23. [Crossref]  [PubMed]
22. Fu Y, Xu F, Jiang L, Miao Z, Liang X, Yang J, et al. Circu- lating vitamin C concentration and risk of cancers: a Mende- lian randomization study. BMC medicine. 2021; 19(1), 171. [Crossref]  [PubMed]
23. Wang W, Hu W, Xue S, Chen Q, Jiang Y, Zhang H, et al. Vitamin D and Lung Cancer; Association, Prevention, and Treatment. Nutrition and cancer. 2021; 73(11-12), 2188-2200. [Crossref]  [PubMed]
24. Chen GC, Zhang ZL, Wan Z, Wang L, Weber P, Eggersdorfer M, et al. Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis. Cancer causes & con- trol : CCC. 2015; 26(12), 1719-1728. [Crossref]  [PubMed]
25. Zhang L, Wang S, Che X, Li X. Vitamin D and lung cancer risk: a comprehensive review and meta-analysis. Cellular physiology and biochemistry : international journal of ex- perimental cellular physiology, biochemistry, and pharma- cology. 2015, 36(1), 299-305. [Crossref]  [PubMed]
26. Muller DC, Hodge AM, Fanidi A, Albanes D, Mai XM, Shu XO et al. No association between circulating concentra- tions of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3). Annals of oncology : official journal of the European Society for Medical Oncology. 2018; 29(6), 1468-1475. [Crossref]  [PubMed]
27. Liu J, Dong Y, Lu C, Wang Y, Peng L, Jiang M, et al. Me- ta-analysis of the correlation between vitamin D and lung cancer risk and outcomes. Oncotarget. 2017; 8(46), 81040-81051. [Crossref]  [PubMed]
28. Sigounas G, Anagnostou A, Steiner M. dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr Cancer. 1997; 28:30-5. PubMed: 9200147 [Crossref]  [PubMed]
29. Shklar G, Schwartz JL. Vitamin E inhibits experimental car- cinogenesis and tumour angiogenesis. Eur J Cancer B Oral Oncol. 1996; 32B:114-9. PubMed: 8736173 [Crossref]  [PubMed]
30. Huang J, Weinstein SJ, Yu K, Männistö S, Albanes D. A Prospective Study of Serum Vitamin E and 28-Year Risk of Lung Cancer. J Natl Cancer Inst. 2020 Feb 1;112(2):191-199. [Crossref]  [PubMed]
31. Chen G, Wang J, Hong X, Chai Z, Li Q. Dietary vitamin E intake could reduce the risk of lung cancer: evidence from a meta-analysis. International journal of clinical and exper- imental medicine. 2015; 8(4), 6631-6637. [PubMed]
32. Zhu YJ, Bo YC, Liu XX, Qiu CG. Association of di- etary vitamin E intake with risk of lung cancer: a dose-re- sponse meta-analysis. Asia Pacific journal of clinical nutri- tion. 2017; 26(2), 271-277. [PubMed]
33. Wu QJ, Xiang YB, Yang G, Li HL, Lan Q, et al. Vitamin E intake and the lung cancer risk among female nonsmokers: a report from the Shanghai Women's Health Study. Inter- national journal of cancer. 2015; 136(3), 610-617. [PubMed]
34. Zhao H, Jin X. Causal associations between dietary anti- oxidant vitamin intake and lung cancer: A Mendelian ran- domization study. Front Nutr. 2022;Sep 2;9:965911. [Crossref]  [PubMed]
35. Nimptsch K, Rohrmann S, Kaaks R, Linseisen J . Dietary vitamin K intake in relation to cancer incidence and mor- tality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EP- IC-Heidelberg). The American journal of clinical nutrition. 2010; 91(5), 1348-1358. [Crossref]  [PubMed]
36. Mahabir S, Forman MR, Dong YQ, Park Y, Hollenbeck A, Schatzkin A. Mineral intake and lung cancer risk in the NIH-American Association of Retired Persons Diet and Health study. Cancer epidemiology, biomarkers & preven- tion : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preven- tive Oncology. 2010; 19(8), 1976-1983. [Crossref]  [PubMed]
37. Yan F, Eshak ES, Arafa A, Tamakoshi A, Iso H, & JACC Study Group . Vitamin K Intake and Risk of Lung Cancer: The Japan Collaborative Cohort Study. Journal of epidemi- ology. 2023; 33(10), 536-542. [Crossref]  [PubMed]
38. Muka T, Kraja B, Ruiter R, Lahousse L, de Keyser CE, Hofman A, et al. Dietary mineral intake and lung cancer risk: the Rotterdam Study. European journal of nutrition. 2017; 56(4), 1637-1646. [Crossref]  [PubMed]
39. Kuang Y, Wang Q. Iron and lung cancer. Cancer let- ters. 2019; 464, 56-61. [Crossref]  [PubMed]
40. Wang Q, Cui Q, Gao JP, Xing R . Role of iron biomarkers and iron intakes in lung cancer risk: A systematic review and meta-analysis. Journal of trace elements in medicine and biology: organ of the Society for Minerals and Trace Ele- ments (GMS). 2022; 74, 127060. [Crossref]  [PubMed]
41. Ji M, Li XD, Shi HB, Ning ZH, Zhao WQ, Wang Q, et al. Clinical significance of serum ferritin in elderly patients with primary lung carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014; 35(10), 10195-10199. [Crossref]  [PubMed]
42. Brzóska K, Bartłomiejczyk T, Sochanowicz B, Cymerman M, Grudny J, Kołakowski J, et al. Carcinogenesis-related changes in iron metabolism in chronic obstructive pulmo- nary disease subjects with lung cancer. Oncology letters. 2018; 16(5), 6831-6837. [Crossref]  [PubMed]
43. Feng X, Zhao T, Liu X, Liu Y, Gao Y. Serum iron status and the risk of lung cancer: a two-sample Mendelian-randomiza- tion study. Journal of thoracic disease. 2023; 15(11), 6291-6300. [Crossref]  [PubMed]
44. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF, Jr Slate EH, Fischbach LA, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nut- ritional Prevention of Cancer Trial. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the Ame- rican Society of Preventive Oncology. 2002; 11(7), 630-639. [PubMed]
45. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thomp- son IM, Ford LG, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009; 301(1), 39-51. [PubMed]
46. Karp DD, Lee SJ, Keller SM, Wright GS, Aisner S, Belinsky SA, et al. Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2013; 31(33), 4179-4187. [Crossref]  [PubMed]
47. Lü J, Zhang J, Jiang C, Deng Y, Özten N, Bosland MC . Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges. Nutrition and cancer. 2016; 68(1), 1-17. [Crossref]  [PubMed]
48. Zhang X, Yang Q. Association between serum copper lev- els and lung cancer risk: A meta-analysis. The Journal of International Medical Research. 2018; 46(12), 4863-4873. [Crossref]  [PubMed]
49. Zhang L, Shao J, Tan SW, Ye HP, Shan XY. Association be- tween serum copper/zinc ratio and lung cancer: A system- atic review with meta-analysis. Journal of trace elements in medicine and biology: organ of the Society for Minerals and Trace Elements (GMS). 2022; 74, 127061. [Crossref]  [PubMed]
50. Wang Y, Sun Z, Li A, Zhang Y. Association between serum zinc levels and lung cancer: a meta-analysis of observational studies. World journal of surgical oncology. 2019; 17(1), 78. [Crossref]  [PubMed]
51. Mahabir S, Wei Q, Barrera SL, Dong YQ, Etzel CJ, Spitz MR, et al. Dietary magnesium and DNA repair capacity as risk factors for lung cancer. Carcinogenesis. 2008; 29(5), 949-956. [Crossref]  [PubMed]
52. Chen WJ, Huang RS. Low-folate stress reprograms can- cer stem cell-like potentials and bioenergetics metabolism through activation of mTOR signaling pathway to promote in vitro invasion and in vivo tumorigenicity of lung can- cers. The Journal of nutritional biochemistry. 2018 53, 28- 38. [Crossref]  [PubMed]
53. Jawed, R., & Bhatti, H. (2024). Cuproptosis in lung cancer: therapeutic options and prognostic models. Apoptosis: an international journal on programmed cell death, 29(9-10), 1393-1398. [Crossref]  [PubMed]
54. Elsalahaty MI, Alkafaas SS, Bashir AO, El-Tarabily KA, El-Saadony MT, Yousef EH. Revealing the association be- tween vitamin D metabolic pathway gene variants and lung cancer risk: a systematic review and meta-analysis. Frontiers in genetics 2024; 15, 1302527. [Crossref]  [PubMed]
55. Chen F, Wen T, Lv Q, Liu F. Associations between Folate Metabolism Enzyme Polymorphisms and Lung Cancer: A Meta-Analysis. Nutrition and cancer. 2020; 72(7), 1211-1218. [Crossref]  [PubMed]
56. Chen F, Ni Y, Zhang J, Hao Y, Tian Z, Qiang G . The value of folate receptor-positive circulating tumour cells as a diag- nostic biomarker for lung cancer: a systematic review and meta-analysis. The Journal of international medical research. 2023; 51(9), 3000605231199763. [Crossref]  [PubMed]
57. Peng SM, Yu N, Che J, Xu JY, Chen GC, Li DP, et al. Total, bioavailable and free 25-hydroxyvitamin D are associated with the prognosis of patients with non-small cell lung can- cer. Cancer causes & control: CCC. 2022; 33(7), 983-993. [Crossref]  [PubMed]
58. McFarland DC, Fernbach M, Breitbart WS, Nelson C. Prognosis in metastatic lung cancer: vitamin D deficiency and depression-a cross-sectional analysis. BMJ Support Palliat Care. 2022 Sep;12(3):339-346 [Crossref]  [PubMed]
59. Ma K, Xu W, Wang C, Li B, Su K, Li W. Vitamin D deficien- cy is associated with a poor prognosis in advanced non-small cell lung cancer patients treated with platinum-based first- line chemotherapy. Cancer biomarkers : section A of Disease markers. 2017; 18(3), 297-303. [Crossref]  [PubMed]
60. Shaurova T, Dy GK, Battaglia S, Hutson A, Zhang L, Zhang Y, et al. Vitamin D3 Metabolites Demonstrate Prog- nostic Value in EGFR-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resis- tance. Cancers. 2020 12(3), 675. [Crossref]  [PubMed]
61. Pineda Lancheros LE, Pérez Ramírez C, Sánchez Martín A, Gálvez Navas JM, Martínez Martínez F, Ramírez Tortosa MDC et al. Impact of Genetic Polymorphisms on the Meta- bolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer. Nutrients. 2021; 13(11), 3783. [Crossref]  [PubMed]
62. Kong J, Chen X, Wang J, Li J, Xu F, Gao S, et al. Genetic Polymorphisms in the Vitamin D Pathway and Non-small Cell Lung Cancer Survival. Pathology oncology research : POR. 2020; 26(3), 1709-1715. [Crossref]  [PubMed]
63. Gao, Y., & Ge, J. T. (2022). Prognostic role of pretreatment serum ferritin concentration in lung cancer patients: A me- ta-analysis. World journal of clinical cases, 10(33), 12230- 12239. [Crossref]  [PubMed]
64. Wang F, Deng G, Liang N, Hu P, Liu K, Liu T, et al. Serum ferritin level is an effective prognostic factor for lung can- cer immunotherapy. Cancer biology & therapy. 2023; 24(1), 2285367. [Crossref]  [PubMed]
65. Zabłocka-Słowińska K, Prescha A, Płaczkowska S, Porębska I, Kosacka M, Pawełczyk K. Serum and Whole Blood Cu and Zn Status in Predicting Mortality in Lung Cancer Pa- tients. Nutrients. 2020; 13(1), 60. [Crossref]  [PubMed]
66. Wang W, Wang X, Luo J, Chen X, Ma K, He H, et al. Se- rum Copper Level and the Copper-to-Zinc Ratio Could Be Useful in the Prediction of Lung Cancer and Its Prognosis: A Case-Control Study in Northeast China. Nutrition and can- cer. 2021; 73(10), 1908-15. [Crossref]  [PubMed]
67. Pietrzak S, Wójcik J, Scott RJ, Kashyap A, Grodzki T, Baszuk P, et al. Influence of the selenium level on overall survival in lung cancer. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS). 2019; 56, 46-51. [Crossref]  [PubMed]
68. Zhu Y, Pu Q, Zhang Q Liu Y, Ma Y, Yuan Y, et al. Seleni- um-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Cancer Med. 2023;12(16):17149-17170. [Crossref]  [PubMed]
69. Zarogoulidis P, Cheva A, Zarampouka K, Huang H, Li C, Huang Y, et al. Tocopherols and tocotrienols as anticancer treatment for lung cancer: future nutrition. Journal of tho- racic disease. 2013; 5(3), 349-352. [PubMed]
70. Tripathi SK, Pandey K, Panda M, Spinella MJ, Rengasamy KR, Biswal BK . The potential of retinoids for combination therapy of lung cancer: Updates and future directions. Phar- macological research. 2019; 147, 104331. [Crossref]  [PubMed]
71. Ou J, Zhu X, Chen P, Du Y, Lu Y, Peng X, et al. A randomi- zed phase II trial of best supportive care with or without hy- perthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer. Journal of advanced research. 2020; 24, 175-182.) [Crossref]  [PubMed]
72. Ou J, Liao Q, Du Y, Xi W, Meng Q, Li K, et al. SERPINE1 and SERPINB7 as potential biomarkers for intravenous vi- tamin C treatment in non-small-cell lung cancer. Free rad- ical biology & medicine. 2023; 209(Pt 1), 96-107. [Crossref]  [PubMed]
73. Cusato J, Genova C, Tomasello C, Carrega P, Ottonello S, Pietra G, et al. Influence of Vitamin D in Advanced Non- Small Cell Lung Cancer Patients Treated with Nivolum- ab. Cancers. 2019; 11(1), 125. [Crossref]  [PubMed]
74. Bayanbold K, Singhania M, Fath MA, Searby CC, Stolwijk JM, Henrich JB, et al. Depletion of Labile Iron Induces Rep- lication Stress and Enhances Responses to Chemoradiation in Non-Small-Cell Lung Cancer. Antioxidants (Basel, Swit- zerland). 2023 12(11), 2005.) [Crossref]  [PubMed]
75. Wu Z, Dai Y, Chen LA. The Prediction Of Epidermal Growth Factor Receptor Mutation And Prognosis Of EGFR Tyro- sine Kinase Inhibitor By Serum Ferritin In Advanced NS- CLC. Cancer management and research. 2019; 11, 8835-8843. [Crossref]  [PubMed]
76. Shi HB, Li XD, Jiang JT, Zhao WQ, Ji M, Wu CP. Serum ferritin is elevated in advanced non-small cell lung cancer patients and is associated with efficacy of platinum-based chemotherapy. Journal of cancer research and therapeu- tics. 2014; 10(3), 681-685. [Crossref]  [PubMed]
77. Gröber U, Holzhauer P, Kisters K, Holick MF, Adamietz IA . Micronutrients in Oncological Intervention. Nutrients. 2016; 8(3), 163. [Crossref]  [PubMed]
78. Mix M, Ramnath N, Gomez J, de Groot C, Rajan S, Di- baj S, et al. Effects of selenomethionine on acute toxicities from concurrent chemoradiation for inoperable stage III non-small cell lung cancer. World journal of clinical on- cology. 2015; 6(5), 156-165. [Crossref]  [PubMed]
79. Miya T, Kondo H, Gemma A. Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting. International journal of clinical oncol- ogy. 2018; 23(6), 1196-1200. [Crossref]  [PubMed]
80. Lu CW, Pang JS, Ko YS, Chang CJ, Wang CW, Chen WT, et al. Zinc deficiency associated with cutaneous toxicities in- duced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma. Jour- nal of the European Academy of Dermatology and Venere- ology: JEADV. 2023; 37(2), 328-339. [Crossref]  [PubMed]
81. You W, Liu X, Tang H, Lu B, Zhou Q, Li Y, et al. Vitamin D Status Is Associated with Immune Checkpoint Inhibitor Efficacy and Immune-related Adverse Event Severity in Lung Cancer Patients: A Prospective Cohort Study. Journal of immunotherapy. 2023 (Hagerstown, Md.: 1997), 46(6),236-243. [Crossref]  [PubMed]